15 insiders reported 112 Form 4 transactions for Sarepta Therapeutics, Inc. (SRPT) over the past 18 months (most recent 2026-06-05). Recent activity: BEHRENS M KATHLEEN (Director) Buy 16,875 shares, Connelly Deirdre P (Director) Buy 16,875 shares, Wigzell Hans Lennart Rudolf (Director) Buy 16,875 shares, Barry Richard (Director) Buy 16,875 shares, Nicaise Claude (Director) Buy 16,875 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | BEHRENS M KATHLEEN | Director | Buy | 16,875 | $0 |
| 2026-06-05 | Connelly Deirdre P | Director | Buy | 16,875 | $0 |
| 2026-06-05 | Wigzell Hans Lennart Rudolf | Director | Buy | 16,875 | $0 |
| 2026-06-05 | Barry Richard | Director | Buy | 16,875 | $0 |
| 2026-06-05 | Nicaise Claude | Director | Buy | 16,875 | $0 |
| 2026-06-05 | Boor Kathryn Jean | Director | Buy | 16,875 | $0 |
| 2026-06-05 | Mayo Stephen | Director | Buy | 16,875 | $0 |
| 2026-06-05 | Chambers Michael Andrew | Director | Buy | 16,875 | $0 |
| 2026-03-13 | Rodino-Klapac Louise | President, R&D and Tech Ops | Sell | 948 | $16,144 |
| 2026-03-13 | Mayo Stephen | Director | Sell | 7,239 | $123,208 |
| 2026-03-13 | Estepan Ian Michael | Chief Operating Officer | Sell | 1,097 | $18,682 |
| 2026-03-13 | Rothfuss Cristin | EVP, General Counsel | Sell | 974 | $16,587 |
| 2026-03-13 | Wong Ryan Ho-Yan | Chief Financial Officer | Sell | 256 | $4,360 |
| 2026-03-11 | Wong Ryan Ho-Yan | Chief Financial Officer | Sell | 162 | $2,746 |
| 2026-03-11 | Wong Ryan Ho-Yan | Chief Financial Officer | Sell | 113 | $1,915 |
| 2026-03-11 | Rodino-Klapac Louise | President, R&D and Tech Ops | Sell | 504 | $8,543 |
| 2026-03-11 | Rodino-Klapac Louise | President, R&D and Tech Ops | Sell | 895 | $15,170 |
| 2026-03-11 | Estepan Ian Michael | Chief Operating Officer | Sell | 1,036 | $17,560 |
| 2026-03-11 | Estepan Ian Michael | Chief Operating Officer | Sell | 583 | $9,882 |
| 2026-03-11 | Rothfuss Cristin | EVP, General Counsel | Sell | 484 | $8,204 |
| 2026-03-11 | Rothfuss Cristin | EVP, General Counsel | Sell | 346 | $5,865 |
| 2026-03-03 | Estepan Ian Michael | Chief Operating Officer | Buy | 8,125 | $0 |
| 2026-03-03 | Estepan Ian Michael | Chief Operating Officer | Sell | 3,301 | $53,476 |
| 2026-03-03 | Estepan Ian Michael | Chief Operating Officer | Sell | 875 | $14,175 |
| 2026-03-03 | Rothfuss Cristin | EVP, General Counsel | Sell | 408 | $6,610 |
Source: SEC Form 4 filings · as of 2026-06-05